BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6239401)

  • 1. [Chronic lymphocytic leukemia of T-cells with a suppressor phenotype (T3+, T4-, T8+). Report of 2 cases].
    Calabuig MT; Outeiriño J; Escudero A; Prieto ME; Pérez-Rus MG; Pérez Sánchez MI; Méndez MM; Sánchez-Fayos J
    Sangre (Barc); 1984; 29(4-A):449-56. PubMed ID: 6239401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma and leukemia of t-lymphocytes.
    Watanabe S; Shimosato Y; Shimoyama M
    Pathol Annu; 1981; 16(Pt 2):155-203. PubMed ID: 7036059
    [No Abstract]   [Full Text] [Related]  

  • 4. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
    Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
    Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
    Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
    J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic classification of lymphoproliferative disorders in the bone marrow.
    Bartl R; Frisch B; Kettner G; Hill W; Hoffmann-Fezer G; Sund M; Burkhardt R
    Bibl Haematol; 1984; (50):98-127. PubMed ID: 6331825
    [No Abstract]   [Full Text] [Related]  

  • 7. Normal and malignant T cells in the regulation of inflammation and immunity.
    Broder S
    Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
    Pintado Cros T
    Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic lymphoproliferative disorders: classification and diagnosis.
    Litz CE; Brunning RD
    Baillieres Clin Haematol; 1993 Dec; 6(4):767-83. PubMed ID: 8038489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report of a case of T-cell-derived chronic lymphocytic leukemia with antibodies to adult T-cell leukemia-associated antigens.
    Utsunomiya A; Matsumoto M; Matsumoto T; Nishioka K; Iwahashi M; Hanada S; Nomura K; Hashimoto S; Yunoki K
    Jpn J Clin Oncol; 1983; 13 Suppl 2():291-9. PubMed ID: 6603537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte phenotyping and its diagnostico-clinical use].
    Gianotti A; Moscatelli P
    G Clin Med; 1987; 68(8-9):453-6. PubMed ID: 3500885
    [No Abstract]   [Full Text] [Related]  

  • 12. Human T-derived lymphoproliferative diseases.
    Brouet JC; Preud'homme JL; Flandrin G; Seligmann M
    Recent Results Cancer Res; 1978; 64():131-7. PubMed ID: 366691
    [No Abstract]   [Full Text] [Related]  

  • 13. [T-cell neoplasms with helper or suppressor activity].
    Rupniewska ZM
    Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic and clinical spectrum of post-thymic T-cell malignancies.
    Jaffe ES
    Cancer Invest; 1984; 2(5):413-26. PubMed ID: 6093950
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell chronic lymphocytic leukemia with morphologic and immunologic characteristics of cytotoxic/suppressor phenotype.
    Phyliky RL; Li CY; Yam LT
    Mayo Clin Proc; 1983 Nov; 58(11):709-20. PubMed ID: 6226834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Tr-cell lymphoproliferative disease with unusual phenotype: clinical, cytochemical, ultrastructural and immunological studies.
    Chen Z; Wang ZC; Shen DC; Tang MH; Qi SL; Lin ZX; Li LQ; Zhu LP; Fang F; Chen D
    Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(3):140-6. PubMed ID: 2965387
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T8 chronic lymphocytic leukemia. A distinctive disorder related to T8 lymphocytosis.
    Brisbane JU; Berman LD; Osband ME; Neiman RS
    Am J Clin Pathol; 1983 Sep; 80(3):391-6. PubMed ID: 6224415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
    Dillman RO; Shawler DL; Dillman JB; Royston I
    J Clin Oncol; 1984 Aug; 2(8):881-91. PubMed ID: 6379121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.